Close Menu

NEW YORK ─ Eurofins Technologies said on Wednesday that it has received CE-IVD marking for its Ingezim COVID 19 DR total antibody assay for the indirect diagnosis of past exposure to SARS-CoV-2.

The test is a dual recognition enzyme-linked immunosorbent assay (ELISA) that can detect total SARS-CoV-2 virus nucleoprotein-specific antibodies, including IgG, IgM, and IgA, without differentiating between them.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.